osapiens Medical Devices User Group

The community where UDI professionals stay ahead.

05.03 | 09.04 | 21.05. | 02.07. | 24.09. | 15.10. | 17.12.
3:00 - 4:00 PM (CET)

English

The osapiens Medical Devices User Group is a regular online session for compliance, regulatory affairs, UDI, and master data professionals navigating the fast-moving world of medical device regulations – from EUDAMED to global UDI submissions across Australia, Switzerland, the US, and beyond.

Each session cuts straight to what matters: what has changed, what it means for your day-to-day work, and what you should be doing next. You won't get a sales pitch. You'll get a working agenda.

Image
Image

Your host: Lionel Tussau, Lead Healthcare at osapiens

Lionel is Chair of the MedTech Europe EUDAMED IT Expert Group, part of the MTE core UDI team, and a member of the GS1 Global Healthcare Leadership Team – meaning he's not just following regulatory developments, he's helping shape them.

The insights he brings to each session come directly from the working groups, Commission workshops, and industry coordination meetings where the details actually get decided. What you hear reflects what's happening, not what the press release will say three months later.

What we cover in this series:

Our User Group sessions track the developments that matter most to manufacturers, authorized representatives, and compliance teams – across regulatory databases, global UDI submissions, and trading partner data exchanges, including:

EUDAMED: mandatory use timelines, module status, data quality challenges, and what "submitted" vs "registered" actually means for your devices

swissdamed: Switzerland's UDI registration requirements, deadlines, and how it relates (and doesn't) to EUDAMED

AusUDID: Australia's UDI database, M2M connectivity, and open questions around publication coordination

FDA GUDID, China NMPA, Saudi Arabia, Taiwan: submission status and connector updates for global rollout

Every session brings you up to speed on where things stand, what questions remain open, and how to move forward without creating unnecessary rework.

Who Should Attend

Regulatory Operations & UDI Compliance Leaders